Introduction: A balanced person is able to spread time (and energy) optimally across the different life domains. Especially in people with multiple sclerosis (MS) the ability to self-steer an optimal balance in daily activity may be compromised. Objective: To evaluate cross-cultural, construct validity and test-retest reliability, of the translated versions of the Life Balance Inventory (LBI) in people with MS within different European cultures (Danish, French, Spanish, Slovenian, Dutch and Flemish). Method: The LBI was translated according to the principles of translation and cultural adaption process of patient-reported outcomes and evaluated in people with MS in each country/language area. To evaluate construct validity, correlations ...
Objective: To assess overall resource consumption, work capacity and quality of life of patients wit...
Health-related quality of life measurements are gaining more importance in the study and clinical pr...
IIntroduction: In order to estimate the value of interventions in multiple sclerosis (MS) - where li...
Background: Inconsistent use of generic and disease-specific health-related quality of life (HRQOL) ...
Objective—To assess the quality of life (QoL) of patients with multiple sclerosis in France, Germany...
Aim of the study: Is to examine balance of people who has multiple sclerosis (MS) and find out the r...
International audienceBackground: The perception of diagnosis announcement, the social support and t...
Contains fulltext : 155378.pdf (publisher's version ) (Open Access)BACKGROUND: In ...
Multiple sclerosis (MS) is a major cause of disability and poor quality of life (QOL). Previous stud...
AbstractBackgroundThe Patient-Reported Indices for Multiple Sclerosis (PRIMUS) comprises a suite of ...
Background: The Patient-Reported Indices for Multiple Sclerosis (PRIMUS) comprises a suite of three ...
Background: Fatigue is a disabling symptom of multiple sclerosis (MS) and impacts on daily life. The...
Background: Multiple sclerosis (MS) is a chronic disease associated with several impacts; especially...
Marta Aymerich1, Imma Guillamón2, Albert J Jovell3,41Medical Sciences Department, Univers...
ABSTRACT More than 700,000 people suffer from multiple sclerosis (MS) in Europe. This implies that ...
Objective: To assess overall resource consumption, work capacity and quality of life of patients wit...
Health-related quality of life measurements are gaining more importance in the study and clinical pr...
IIntroduction: In order to estimate the value of interventions in multiple sclerosis (MS) - where li...
Background: Inconsistent use of generic and disease-specific health-related quality of life (HRQOL) ...
Objective—To assess the quality of life (QoL) of patients with multiple sclerosis in France, Germany...
Aim of the study: Is to examine balance of people who has multiple sclerosis (MS) and find out the r...
International audienceBackground: The perception of diagnosis announcement, the social support and t...
Contains fulltext : 155378.pdf (publisher's version ) (Open Access)BACKGROUND: In ...
Multiple sclerosis (MS) is a major cause of disability and poor quality of life (QOL). Previous stud...
AbstractBackgroundThe Patient-Reported Indices for Multiple Sclerosis (PRIMUS) comprises a suite of ...
Background: The Patient-Reported Indices for Multiple Sclerosis (PRIMUS) comprises a suite of three ...
Background: Fatigue is a disabling symptom of multiple sclerosis (MS) and impacts on daily life. The...
Background: Multiple sclerosis (MS) is a chronic disease associated with several impacts; especially...
Marta Aymerich1, Imma Guillamón2, Albert J Jovell3,41Medical Sciences Department, Univers...
ABSTRACT More than 700,000 people suffer from multiple sclerosis (MS) in Europe. This implies that ...
Objective: To assess overall resource consumption, work capacity and quality of life of patients wit...
Health-related quality of life measurements are gaining more importance in the study and clinical pr...
IIntroduction: In order to estimate the value of interventions in multiple sclerosis (MS) - where li...